Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Cancer Discovery|December 7, 2016
Oncogenic MET as an Effective Therapeutic Target in Non-Small Cell Lung Cancer Resistant to EGFR Inhibitors: The Rise of the PhoenixLivio TrusolinoCancer Discovery|April 6, 2021
Rational Treatment of Metastatic Colorectal Cancer: A Reverse Tale of Men, Mice, and Culture DishesMarco Avolio, Livio TrusolinoBiochimica Et Biophysica Acta|July 16, 2014
Inhibition of poly(ADP-ribosyl)ation in cancer: old and new paradigms revisitedBarbara Lupo, Livio TrusolinoCancer Discovery|August 4, 2021
The gRASs Is Greener: Potential New Therapies in Lung Cancer with Acquired Resistance to KRASG12C InhibitorsMarika Pinnelli, Livio TrusolinoCancer Cell|July 10, 2019
The Stromal and Immune Landscape of Colorectal Cancer Progression during Anti-EGFR TherapyIrene Catalano, Livio TrusolinoCancer Discovery|October 17, 2012
Compensatory pathways in oncogenic kinase signaling and resistance to targeted therapies: six degrees of separationLivio Trusolino, Andrea BertottiEMBO Molecular Medicine|September 29, 2011
Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perilsDavide Torti, Livio TrusolinoNature Reviews. Cancer|May 11, 2002
Scatter-factor and semaphorin receptors: cell signalling for invasive growthLivio Trusolino, Paolo M ComoglioJournal of Molecular Medicine (Berlin, Germany)|May 10, 2014
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategiesSimonetta M Leto, Livio TrusolinoNature Reviews. Cancer|April 21, 2018
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapyPaolo M Comoglio, Livio Trusolino, Carla BoccaccioPageof 12